Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy

International Journal of Molecular Sciences(2024)10.3390/ijms25179507Source: DataRank Database

Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy is a research paper published in International Journal of Molecular Sciences (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.

N/A

0.269DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 2.02)OA: goldTopics (86)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.269

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (9)

Prabuddha Waduge ORCID,Avinash Kaur ORCID,Hong Tian ORCID,Christina Y. Weng ORCID,J. Timothy Stout

Live enrichment

PubMed:39273454 PMC:PMC11394726 OpenAlex:https://openalex.org/W4402168990

NIH grants

Grant: R01EY036417

NIH grants

Grant: R01EY027749

NIH grants

Grant: R24EY028764

NIH grants

Grant: R43EY031238

NIH grants

Grant: R43EY032827

NIH grants

Grant: R21EY035421

NIH grants

Grant: R44EY027665

NIH grants

Grant: P30EY002520

National Institutes of Health

Grant: 1R01EY036417-01

Paradoxical role of anti-VEGF therapy in subretinal fibrosis of wet AMD

National Institutes of Health

Grant: 7R24EY028764-03

A selective angiogenesis blocker to treat retinopathy of prematurity

National Institutes of Health

Grant: 5P30EY002520-40

P30 - Core Grant for Vision Research

National Institutes of Health

Grant: 5R01EY027749-03

A Diabetic Retinopathy-Associated Vascular Permeability Factor

National Institutes of Health

Grant: 1R21EY035421-01

Developing a novel disease-targeted anti-angiogenic therapy for CNV

National Institutes of Health

Grant: 1R43EY032827-01

A new drug entity for combination therapy of diabetic retinopathy

National Institutes of Health

Grant: 5R44EY027665-03

Developing a novel therapy for diabetic retinopathy

National Institutes of Health

Grant: 1R43EY031238-01

Anti-angiogenic gene therapy of ocular vascular diseases

FWCI

2.02

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/25/17/9507/pdf?version=1725175237

GOLDhttps://doi.org/10.3390/ijms25179507

publisherhttps://www.mdpi.com/1422-0067/25/17/9507/pdf?version=1725175237

publisherhttps://www.mdpi.com/1422-0067/25/17/9507/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39273454

Fields of Study

Retinal Diseases and TreatmentsRetinal Development and DisordersRetinal and Macular SurgeryMedicine03 medical and health sciences0302 clinical medicineDiabetic RetinopathyHumansAnimalsMiceHuman Umbilical Vein Endothelial CellsAntibodies, NeutralizingAngiogenesis InhibitorsCell MovementCell ProliferationAntibodies, Monoclonal, HumanizedMice, Inbred C57BLRNA-Binding ProteinsAdaptor Proteins, Signal Transducing

MeSH Terms

AnimalsCell MovementDiabetic RetinopathyHumansMice, Inbred C57BLRNA-Binding ProteinsAngiogenesis InhibitorsAdaptor Proteins, Signal TransducingCell ProliferationMiceAntibodies, NeutralizingAntibodies, Monoclonal, HumanizedHuman Umbilical Vein Endothelial Cells

Keywords

Umbilical veinMonoclonal antibodyAntibodyIn vivoIn vitroDiabetic retinopathyMedicineHumanized antibodyPharmacologyNeovascularizationHuman umbilical vein endothelial cellImmunologyAngiogenesisChemistryCancer researchBiologyBiochemistryEndocrinologyDiabetes mellitusBiotechnologyChoroidal neovascularizationScg3Secretogranin IiiAnti-scg3 TherapyScg3-neutralizing Antibodies570Medical Sciences610Angiogenesis InhibitorsInbred C57BLAntibodies, Monoclonal, HumanizedAntibodiesArticleMiceCell MovementMonoclonalMedical SpecialtiesMedicine and Health SciencesHuman Umbilical Vein Endothelial CellsHumansAnimalsNeutralizingHumanizedCell ProliferationAdaptor Proteins, Signal TransducingDiabetesSignal TransducingAdaptor ProteinsRNA-Binding ProteinsAntibodies, NeutralizingMice, Inbred C57BLOphthalmologyand MetabolismOptometry

Sustainable Development Goals

SDG 0: Good health and well-being